A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer
Status:
Completed
Trial end date:
2019-01-14
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to investigate the safety of prexasertib in combination
with other anti-cancer drugs (cisplatin or cetuximab) and radiation therapy in participants
with locally advanced head and neck cancer. The study has two parts (A and B). Participants
will only enroll in one part.